Galectin Therapeutics General and Administrative Expenses | GALT

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Galectin Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
5.8 M	5.86 M	5.94 M	6.62 M	6.36 M	5.47 M	5.97 M	7.13 M	4.53 M	6.16 M	6.96 M	7 M	6.42 M	5.37 M	6.86 M	3.82 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.13 M	3.82 M	6.02 M

Quarterly General and Administrative Expenses Galectin Therapeutics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.85 M	1.59 M	1.36 M	1.41 M	-	1.47 M	1.48 M	1.59 M	-	1.43 M	1.63 M	1.54 M	-	1.52 M	1.59 M	1.88 M	-	1.63 M	1.74 M	1.42 M	-	1.15 M	1.42 M	1.44 M	-	1.36 M	1.5 M	1.72 M	-	1.18 M	2.28 M	1.88 M	-	911 K	1.07 M	1.17 M	-	1.25 M	1.3 M	2.44 M	-	1.44 M	2.06 M	1.7 M	-	1.5 M	1.78 M	2.07 M	-	2.35 M	1.2 M	1.46 M	-	1.49 M	1.45 M	1.05 M	-	1.38 M	1.7 M	1.27 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.44 M	911 K	1.55 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Ionis Pharmaceuticals IONS	394 M	$ 43.5	0.62 %	$ 6.96 B	USA
Agios Pharmaceuticals AGIO	180 M	$ 31.25	0.88 %	$ 1.81 B	USA
Foghorn Therapeutics FHTX	27.6 M	$ 2.0	0.74 %	$ 126 M	USA
Inhibikase Therapeutics IKT	23.6 M	$ 2.0	0.5 %	$ 197 M	USA
Kamada Ltd. KMDA	18.7 M	$ 8.0	1.34 %	$ 461 M	Israel
Intellia Therapeutics NTLA	120 M	$ 12.75	4.0 %	$ 1.38 B	USA
Ultragenyx Pharmaceutical RARE	349 M	$ 14.5	3.19 %	$ 1.43 B	USA
Viridian Therapeutics VRDN	95.3 M	$ 19.0	2.16 %	$ 1.93 B	USA
AbbVie ABBV	14 B	$ 265.76	1.12 %	$ 470 B	USA
AbCellera Biologics ABCL	83.2 M	$ 13.78	0.29 %	$ 4.12 B	Canada
Abeona Therapeutics ABEO	65 M	$ 5.11	1.59 %	$ 271 M	USA
Arbutus Biopharma Corporation ABUS	15.9 M	$ 4.67	4.94 %	$ 895 M	Canada
ACADIA Pharmaceuticals ACAD	549 M	$ 20.11	0.8 %	$ 3.39 B	USA
Achieve Life Sciences ACHV	16.3 M	$ 7.01	0.13 %	$ 306 M	USA
AC Immune SA ACIU	16.1 M	$ 2.71	0.55 %	$ 273 M	Schweiz
Aclaris Therapeutics ACRS	22 M	$ 4.27	0.79 %	$ 523 M	USA
Adagene ADAG	7.08 M	$ 2.8	0.28 %	$ 165 M	China
ADC Therapeutics SA ADCT	36.6 M	$ 1.23	8.85 %	$ 156 M	Schweiz
Adial Pharmaceuticals ADIL	5.18 M	$ 4.35	5.58 %	$ 2.91 M	USA
ADMA Biologics ADMA	91.6 M	$ 10.11	4.01 %	$ 2.41 B	USA
Adaptive Biotechnologies Corporation ADPT	72.7 M	$ 29.84	5.26 %	$ 4.53 B	USA
Agenus AGEN	54.4 M	$ 8.73	4.43 %	$ 260 M	USA
AIM ImmunoTech AIM	7.7 M	$ 0.19	5.56 %	$ 308 K	USA
Akebia Therapeutics AKBA	107 M	$ 0.91	5.26 %	$ 234 M	USA
Akari Therapeutics, Plc AKTX	9.28 M	$ 8.76	0.46 %	$ 590 B	Britain
Aldeyra Therapeutics ALDX	9.6 M	$ 0.92	4.88 %	$ 55.3 M	USA
Alector ALEC	54 M	$ 1.99	9.94 %	$ 205 M	USA
Aligos Therapeutics ALGS	20.7 M	$ 5.4	0.36 %	$ 53.4 M	USA
Alkermes plc ALKS	222 M	$ 42.76	2.42 %	$ 7.04 B	Irlanda
Allogene Therapeutics ALLO	56.8 M	$ 1.5	0.33 %	$ 331 M	USA
Alnylam Pharmaceuticals ALNY	1.21 B	$ 219.89	0.08 %	$ 28.8 B	USA
Altimmune ALT	28.1 M	$ 2.67	0.36 %	$ 235 M	USA
ALX Oncology Holdings ALXO	23.8 M	$ 1.21	1.23 %	$ 64.9 M	USA
Amgen AMGN	7.05 B	$ 402.98	0.08 %	$ 217 B	USA
Amphastar Pharmaceuticals AMPH	85.9 M	$ 25.37	0.39 %	$ 1.19 B	USA
Amarin Corporation plc AMRN	43.8 M	$ 12.09	0.31 %	$ 5.02 B	Irlanda
Amneal Pharmaceuticals AMRX	527 M	$ 20.35	0.25 %	$ 6.38 B	USA
AnaptysBio ANAB	23.4 M	$ 49.2	1.38 %	$ 1.43 B	USA
Anika Therapeutics ANIK	49.1 M	$ 19.73	3.3 %	$ 283 M	USA
ANI Pharmaceuticals ANIP	318 M	$ 72.58	0.55 %	$ 1.46 B	USA
Annexon ANNX	31.7 M	$ 4.2	0.24 %	$ 651 M	USA
Annovis Bio ANVS	4.48 M	$ 1.2	1.69 %	$ 24.7 M	USA
Aprea Therapeutics APRE	6.48 M	$ 0.68	0.16 %	$ 4.45 M	USA
Aptevo Therapeutics APVO	11.8 M	$ 1.8	2.27 %	$ 568 K	USA
Aquestive Therapeutics AQST	79.8 M	$ 4.57	0.44 %	$ 489 M	USA
Arcturus Therapeutics Holdings ARCT	46.1 M	$ 14.66	12.51 %	$ 401 M	Israel
Ardelyx ARDX	337 M	$ 3.39	1.5 %	$ 817 M	USA
argenx SE ARGX	1.37 B	$ 912.87	1.28 %	$ 56 B	Niderland
Armata Pharmaceuticals ARMP	12.4 M	$ 3.66	3.98 %	$ 133 M	USA
Arcutis Biotherapeutics ARQT	275 M	$ 25.15	0.04 %	$ 3.2 B	USA